FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

CJC-1295 (no DAC)

Modified GRF 1-29 · GHRH analog

≥ 99.0%CAS (see DAC-version distinction)GH-Axis Peptides

Overview

CJC-1295 without DAC (Modified GRF 1-29) is a GHRH analog used in growth-hormone-release research. PeptideXpo supplies CJC-1295 no-DAC at ≥99% HPLC purity.

Specifications

CAS
(see DAC-version distinction)
Purity (HPLC)
≥ 99.0%
Common vial sizes
2 mg, 5 mg, 10 mg
MOQ
On request
Lead time
7–14 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification

Related peptides

Buyers who view CJC-1295 (no DAC) also ask about:

Ipamorelin

Ghrelin / GHSR pathway GH-release peptide

≥99.0%
CAS
170851-70-4
Vial
2 mg–10 mg
MOQ on requestGet quote →

CJC-1295 + Ipamorelin

GH-axis blend (CJC-1295 no DAC + Ipamorelin)

≥99.0% per component
CAS
(blend)
Vial
10 mg (5+5)
MOQ on requestGet quote →

Sermorelin

GHRH 1-29 fragment

≥99.0%
CAS
86168-78-7
Vial
2 mg–10 mg
MOQ on requestGet quote →

See full catalog